Compile Data Set for Download or QSAR
Report error Found 20 Enz. Inhib. hit(s) with all data for entry = 50013794
TargetAdenosine kinase(Human)
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50134740((2R,3R,4S,5S)-2-Hydroxymethyl-5-(5-phenyl-4-phenyl...)
Affinity DataIC50: 0.470nMAssay Description:Inhibitory activity against human recombinant adenosine kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenosine kinase(Human)
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50134753((2R,3R,4S,5S)-2-Methyl-5-(5-phenyl-4-phenylamino-p...)
Affinity DataIC50: 0.800nMAssay Description:Inhibitory activity against human recombinant adenosine kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenosine kinase(Human)
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50134756((2S,3S,4R,5R)-2-[4-(4-Fluoro-phenylamino)-5-phenyl...)
Affinity DataIC50: 1.5nMAssay Description:Inhibitory activity against human recombinant adenosine kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenosine kinase(Human)
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50134751((2R,3R,4S,5S)-2-Hydroxymethyl-5-(3-phenyl-4-phenyl...)
Affinity DataIC50: 2.80nMAssay Description:Inhibitory activity against human recombinant adenosine kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenosine kinase(Human)
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50134744((2S,3S,4R,5S)-2-(4-Amino-3-bromo-pyrazolo[3,4-d]py...)
Affinity DataIC50: 4nMAssay Description:Inhibitory activity against human recombinant adenosine kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenosine kinase(Human)
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50090895(2-[4-(4-Fluoro-phenylamino)-5-phenyl-pyrrolo[2,3-d...)
Affinity DataIC50: 5nMAssay Description:Inhibitory activity against human recombinant adenosine kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenosine kinase(Human)
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50134745((2R,3R,4S,5S)-2-Methoxymethyl-5-(5-phenyl-4-phenyl...)
Affinity DataIC50: 15nMAssay Description:Inhibitory activity against human recombinant adenosine kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenosine kinase(Human)
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50134743((2S,3S,4R,5R)-2-(4-Amino-5-iodo-pyrrolo[2,3-d]pyri...)
Affinity DataIC50: 16nMAssay Description:Inhibitory activity against human recombinant adenosine kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenosine kinase(Human)
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50042349(2-(4-Amino-5-iodo-pyrrolo[2,3-d]pyrimidin-7-yl)-5-...)
Affinity DataIC50: 26nMAssay Description:Inhibitory activity against human recombinant adenosine kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenosine kinase(Human)
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50134750((2R,3R,4S,5S)-2-Aminomethyl-5-(5-phenyl-4-phenylam...)
Affinity DataIC50: 36nMAssay Description:Inhibitory activity against human recombinant adenosine kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenosine kinase(Human)
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50134752((2R,3R,4S,5S)-2-Aminomethyl-5-(3-phenyl-4-phenylam...)
Affinity DataIC50: 42nMAssay Description:Inhibitory activity against human recombinant adenosine kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenosine kinase(Human)
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50134742((1R,2R,3S)-2-(4-Amino-5-iodo-pyrrolo[2,3-d]pyrimid...)
Affinity DataIC50: 68nMAssay Description:Inhibitory activity against human recombinant adenosine kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenosine kinase(Human)
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50134754((2S,3S,4R,5R)-2-(4-Amino-3-bromo-pyrazolo[3,4-d]py...)
Affinity DataIC50: 170nMAssay Description:Inhibitory activity against human recombinant adenosine kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenosine kinase(Human)
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50134755((2S,3S,4R,5R)-2-(4-Amino-5-bromo-pyrrolo[2,3-d]pyr...)
Affinity DataIC50: 280nMAssay Description:Inhibitory activity against human recombinant adenosine kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenosine kinase(Human)
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50134739((2S,3S,4R,5R)-2-(4-Amino-5-iodo-pyrrolo[2,3-d]pyri...)
Affinity DataIC50: 400nMAssay Description:Inhibitory activity against human recombinant adenosine kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenosine kinase(Human)
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50134746((2S,3S,4R,5R)-2-(6-Amino-purin-9-yl)-5-hydroxymeth...)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibitory activity against human recombinant adenosine kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenosine kinase(Human)
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50134748((2S,3S,4R,5R)-2-(4-Amino-5-iodo-pyrrolo[2,3-d]pyri...)
Affinity DataIC50: 2.00E+3nMAssay Description:Inhibitory activity against human recombinant adenosine kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenosine kinase(Human)
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50134741((2R,3R,4S,5S)-2-Aminomethyl-5-(6-amino-purin-9-yl)...)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibitory activity against human recombinant adenosine kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenosine kinase(Human)
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50134747((2S,3S,4R,5R)-2-(4-Amino-3-bromo-pyrazolo[3,4-d]py...)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibitory activity against human recombinant adenosine kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenosine kinase(Human)
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50134749((2S,3S,4R,5R)-2-(4-Amino-5-bromo-pyrrolo[2,3-d]pyr...)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibitory activity against human recombinant adenosine kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed